Millipore Sigma Vibrant Logo

SCR713 TagGFP2 Simplicon® RNA

1) To evaluate the Simplicon® expression system in targeted cell(s) before ordering a custom Simplicon® RNA
2) To determine optimal transfection conditions to express the self-replicating RNA in cell lines

TagGFP2 Simplicon® RNA : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
View Products on Sigmaaldrich.com
SCR713
1 kit  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information
      Description
      Catalogue NumberSCR713
      DescriptionTagGFP2 Simplicon® RNA
      Background InformationSimplicon® is a novel system to effect immediate high sustained protein expression of the target gene(s) without the risk of integration. The technology employs a self-replicating RNA based on the Venezuelan equine encephalitis (VEE) genome1. The Simplicon® RNA contains only genes encoding the VEE RNA replication machinery while the structural proteins that are required to make an infectious particle have been completely removed and replaced with the transgene(s) of interest. Because Simplicon® is a synthetic RNA, there is no risk of the transgene(s) integrating into the transfected cell’s genome. Moreover, the self-replicating nature of the Simplicon™ means that the target protein is continuously expressed in the presence of B18R protein and the selective agent, puromycin. The Simplicon® technology has been successfully utilized for efficient human iPSC generation through the sustained expression of critical reprogramming factors, OKSG and OKSG-cMyc1.

      The Simplicon® TagGFP2 RNA Kit was developed to enable the evaluation of the Simplicon® expression system in targeted cell(s) before ordering a custom Simplicon® RNA. Simplicon® TagGFP2 RNA Kit may be used to determine optimal transfection conditions to express the self-replicating RNA in hard-to transfect somatic or primary cells. Simplicon® TagGFP2 expresses an improved variant of the Aequorea macrodactyla GFP-like protein. TagGFP2 exhibits bright green fluorescence comparable to that of EGFP, with excitation/emission maxima at 483 and 506 nm, respectively.
      References
      Product Information
      Components
      • 1.
      • TagGFP2 RNA: (Part No. CS222751) One (1) vial containing 10 µL of RNA (1 ug/uL). Store at -80°C.

        2.
      • B18R RNA: (Part No. CS224516) One (1) vial containing 10 µL of RNA (1 ug/uL). Store at -80°C.
      Quality LevelMQ100
      Applications
      Application1) To evaluate the Simplicon® expression system in targeted cell(s) before ordering a custom Simplicon® RNA
      2) To determine optimal transfection conditions to express the self-replicating RNA in cell lines
      Application NotesThe Simplicon® TagGFP2 RNA Kit was developed to enable the evaluation of the Simplicon® expression system in targeted cell(s) before ordering a custom Simplicon® RNA. Simplicon® TagGFP2 RNA Kit may be used to determine optimal transfection conditions to express the self-replicating RNA in hard-to transfect somatic or primary cells.
      Biological Information
      ConcentrationPlease refer to lot specific datasheet.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality Assurance• Discrete RNA band on RNA gel of appropriate size.
      • GFP-positive cells observed one day after transfection.
      • 40-60% GFP-positive BJ human fibroblasts with FACS analysis.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Packaging Information
      Material Size1 kit
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      SCR713 04054839233357